Oral Abstract Session:
125. Antimicrobials
Saturday, October 31, 2009: 2:00 PM-4:00 PM
Room: 105-AB

Tracks: Adult ID, Investigative ID

Moderators:  George Drusano, MD, Ordway Research Inst and Joshua Nosanchuk, MD, FIDSA, Albert Einstein College of Medicine

Presentations:

2:00 PM
Moderator
Joshua Nosanchuk, MD, FIDSA

2:00 PM
Moderator
George Drusano, MD

2:00 PM
The HCV NS4B RNA Binding Inhibitor, Clemizole, is Highly Synergistic with HCV Protease Inhibitors
Shirit Einav, MD ; Elizabeth Gehrig, MS ; Jeffrey Glenn, MD, PhD ; Hadas Sobol, PhD

2:00 PM
Daptomycin (D) Concentration (Conc) Time Profile in Hemodialysis (HD) Patients (Pts)
George Drusano, MD ; Darren Grabe, PharmD ; Christopher Hoy, MD ; Thomas Lodise, Pharm D ; Shari Meola, RN ; Katie Pallotta, PharmD ; Nimish Patel, PharmD

2:00 PM
Pharmacokinetics (PK) and Safety of 8 and 10 mg/kg of Daptomycin in Pediatric Patients Aged 2 to 6 Years
Susan Abdel-Rahman, MD ; Ronda Akins, MD ; David Benziger, PhD ; John S. Bradley, MD, FIDSA ; Gurudatt Chandorkar, PhD ; Julie Donovan, PharmD ; Richard Jacobs, MD

2:00 PM
Antimicrobial Activity and Wound Healing properties of Nitric Oxide Nanoparticles in a murine model of Acinetobacter baumanii skin infection
Mark Adams, PhD ; Joel Friedman, MD, PhD ; Phillip Gialanella, MS ; George Han, Std ; Luis Martinez, PhD ; Mircea Mihu, MD ; Joshua Nosanchuk, MD, FIDSA ; Uriel Sandkovsky, MD

2:00 PM
CEM-102 (Sodium Fusidate) Dosage Regimen Decision Support Using Population Pharmacokinetic (PPK) and Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Models
Paul G. Ambrose, PharmD, FIDSA ; Sujata Bhavnani, PharmD ; Jurgen Bulitta, PhD ; Prabhavathi Fernandes, PhD ; Alan Forrest, PharmD ; Olanrewaju Okusanya, PharmD, MS ; J. Still, MD, PhD ; Brian Tsuji, PharmD

CME Credits:

ACPE Credits:

ACPE Number: NO CPE CREDIT

Disclosures:

J. Nosanchuk, None

See more of: Oral Abstract Session